🎙️ We’re back with the sixteenth episode of Parkinson Weekly, hosted by Prof. Bas Bloem.

In this episode, Bas discusses the Article of the Week: Mucuna pruriens in untreated Parkinson’s disease in sub-Saharan Africa: A 12-month, multicenter, randomized, controlled trial. He explores the study’s design, key findings, and what this important research tells us about alternative, accessible treatment options for Parkinson’s disease, particularly in under-resourced settings, as well as its broader implications for global Parkinson’s care.

👉 You can read the full article below:

https://pubmed.ncbi.nlm.nih.gov/41269916/

Have a question you’d like Bas to answer in a future episode? Email us at [email protected] – we’d love to hear from you.

🎄🎙️ We’re back with a special Christmas bonus episode of Parkinson Weekly, hosted by Prof. Bas Bloem.

In this festive episode, Bas reflects on the many developments, conversations, and lessons from 2025, offering a thoughtful and wide-ranging look at where Parkinson’s disease research and care stand today. From scientific progress and clinical practice to people, policy, and purpose, he shares his perspective on what has changed — and what still needs to evolve. Bas also looks ahead to the future, outlining his outlook on Parkinson’s disease treatment in the years to come, with a message of realism, optimism, and continued collaboration as we move into the next chapter.

Have a question you’d like Bas to answer in a future episode? Email us at [email protected] – we’d love to hear from you.

🎙️ We’re back with the fifteenth episode of Parkinson Weekly, hosted by Prof. Bas Bloem.

In this week’s episode, Bas explores the next generation of neuromodulation with a focus on Adaptive Deep Brain Stimulation (aDBS), joined by special guest Dr. Martijn Beudel. Together, they unpack how aDBS moves beyond traditional continuous stimulation by dynamically responding to a patient’s brain signals in real time. The discussion highlights the potential of this personalised approach to improve symptom control, reduce side effects, and reshape the future of Parkinson’s disease treatment, while also addressing the clinical challenges and research still needed to bring aDBS into wider practice.

Have a question you’d like Bas to answer in a future episode? Email us at [email protected] – we’d love to hear from you.

🎙️ We’re back with the fourteenth episode of Parkinson Weekly, hosted by Prof. Bas Bloem.

In this week’s episode, Bas delves into the rapidly evolving world of artificial intelligence and its growing influence on Parkinson’s disease care and healthcare in general. He explores how AI-driven tools offer remarkable new possibilities — from earlier diagnosis to personalised treatment strategies — while also highlighting the ethical, clinical, and practical concerns that come with relying on algorithms in healthcare. Bas reflects on how the promise of AI must be balanced with caution, transparency, and rigorous scientific validation.

Have a question you’d like Bas to answer in a future episode? Email us at [email protected] – we’d love to hear from you.

🎙️ We’re back with the thirteenth episode of Parkinson Weekly, hosted by Prof. Bas Bloem.

In this week’s episode, Bas explores the powerful intersection between art and Parkinson’s disease — how creativity, expression, and the artistic process can offer unique insights into living with the condition. From movement and emotion to identity and resilience, Bas reflects on the ways art can illuminate aspects of Parkinson’s that clinical measures often overlook.

The article of the week, “Shades of grey: The continuum of therapies for Parkinson’s disease along the spectrum of credibility” dives into the nuanced landscape of Parkinson’s treatments. Bas discusses how different therapeutic approaches — from well-established evidence-based interventions to emerging and unconventional options — fit along a continuum, and why understanding this spectrum is essential for both clinicians and people with Parkinson’s.

👉 You can read the full article below:

https://pubmed.ncbi.nlm.nih.gov/40746025/

Have a question you’d like Bas to answer in a future episode? Email us at [email protected] – we’d love to hear from you.

🎙️ We’re back with the twelfth episode of Parkinson Weekly, hosted by Prof. Bas Bloem.

In this week’s episode, Bas examines whether today’s clinical study assessments are truly prepared for the future of Parkinson’s research and care. With rapid advances in technology, emerging biomarkers, and new digital tools, long-established rating scales and outcome measures are increasingly being questioned.

Do they genuinely reflect what matters most to people living with Parkinson’s? And how might clinical studies adapt to capture the full complexity of the condition?

Have a question you’d like Bas to answer in a future episode? Email us at [email protected] – we’d love to hear from you.

🎙️ We’re back with the eleventh episode of Parkinson Weekly, hosted by Prof. Bas Bloem.

This week’s Article of the Week delves into the emerging role of faecal microbiota transplantation (FMT) as a potential treatment for Parkinson’s disease.

Building on growing evidence linking gut health and neurological function, the study examines whether restoring a healthy gut microbiome could help alleviate symptoms and possibly influence disease progression.

👉 You can read the full article below:

https://jamanetwork.com/journals/jamaneurology/fullarticle/2821254

Have a question you’d like Bas to answer in a future episode? Email us at [email protected] – we’d love to hear from you.

🎙️We’re back with the tenth episode of Parkinson Weekly, hosted by Prof. Bas Bloem.

This week’s Article of the Week explores an exciting and rapidly evolving field of research — the potential for lifestyle interventions to not only alleviate symptoms but also influence the underlying disease process in Parkinson’s.

From exercise and diet to sleep and stress management, the discussion sheds light on how small, evidence-based lifestyle changes can make a meaningful difference in patients’ lives — and what the latest science reveals about their role in long-term disease modification.

👉 You can read the full article below:

https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(25)00305-9/abstract?rss=yes

Have a question you’d like Bas to answer in a future episode? Email us at [email protected] – we’d love to hear from you.

🎙️ We’re back with the ninth episode of Parkinson Weekly, hosted by Prof. Bas Bloem.

In this special episode, Professor Bas Bloem shares his top book recommendations on Parkinson’s disease — a hand-picked selection of titles that offer insight, inspiration, and understanding for anyone affected by or interested in the condition.

From personal stories and patient perspectives to the latest scientific research and clinical wisdom, Bas introduces each book with a brief description of why it stands out and what makes it a must-read.

Tune in to discover which books have shaped his thinking and continue to inspire his work in Parkinson’s care and research.

Have a question you’d like Bas to answer in a future episode? Email us at [email protected] – we’d love to hear from you.

🎙️ We’re back with the eighth episode of Parkinson Weekly, hosted by Prof. Bas Bloem.

This week’s Article of the Week highlights a fascinating and innovative area of research:

In this episode, Professor Bas Bloem reviews the study 'Association of ultra-processed food consumption with prodromal, incident Parkinson's disease and mortality'. Tune in as he discusses how dietary choices might influence the risk and progression of Parkinson’s disease.

👉 You can read the full article below:

https://pubmed.ncbi.nlm.nih.gov/40675802/

Have a question you’d like Bas to answer in a future episode? Email us at [email protected] – we’d love to hear from you.